Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review

Authors

  • Sikandar Ali Khan Peshawar Medical College, Peshawar
  • Hina Hakim Peshawar Medical College, Peshawar
  • Farzana Salman Peshawar Medical College, Peshawar
  • Shamaila Wadud Peshawar Medical College, Peshawar
  • Sara Yar Khan Peshawar Medical College, Peshawar
  • Momina Haq Peshawar Medical College, Peshawar

DOI:

https://doi.org/10.37762/jgmds.13-3.890

Keywords:

Chronic obstructive pulmonary disease, Vitamin D, Immune status, Respiratory function, Inflammation, Systematic review

Abstract

ABSTRACT

OBJECTIVES

To systematically review recent evidence on the effects of vitamin D on respiratory function and immune status in patients with COPD.

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by persistent airflow limitation, recurrent exacerbations, systemic inflammation, and impaired quality of life. Vitamin D has immunomodulatory and anti-inflammatory effects and has been investigated for its possible role in COPD progression and clinical outcomes.

METHODOLOGY

Eligible studies were identified through searches of PubMed, Web of Science, and Scopus. Search terms included vitamin D, COPD, respiratory function, inflammation, and immune status. Original human studies published between 2020 and 2025 were included. Eligible study designs included randomized controlled trials, cohort studies, case-control studies, longitudinal studies, and cross-sectional studies. Reviews, meta-analyses, pilot studies, case reports, case series, editorials, conference abstracts, and animal studies were excluded. Study selection was conducted according to PRISMA 2020 guidelines. Data were extracted narratively, and methodological quality was assessed using the Cochrane Risk of Bias 2 tool and Joanna Briggs Institute appraisal checklists.

RESULTS
A total of 512 records were identified, of which 18 original studies met the eligibility criteria for qualitative synthesis. Most studies showed that low serum 25-hydroxyvitamin D levels were associated with poorer lung function, greater symptom burden, increased risk of acute exacerbations, and higher inflammatory activity in COPD. Evidence from supplementation trials was inconsistent. Some studies reported improvement in exacerbation frequency and symptom scores, whereas others found no significant overall benefit.

CONCLUSION

Low vitamin D status appears to be associated with adverse respiratory and immune-inflammatory outcomes in patients with COPD. Current evidence does not support universal vitamin D supplementation for all COPD patients; however, assessment and correction of deficiency may be useful in selected high-risk or deficient patients. Further large, well-designed trials are needed to clarify the clinical relevance of vitamin D in COPD

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Sikandar Ali Khan, Peshawar Medical College, Peshawar

Assistant Professor,
Department of Biochemistry,
Peshawar Medical College, Peshawar

Hina Hakim, Peshawar Medical College, Peshawar

Assistant Professor,
Department of Biochemistry,
Peshawar Medical College, Peshawar

Farzana Salman , Peshawar Medical College, Peshawar

Professor,
Department of Physiology,
Peshawar Medical College, Peshawar

Shamaila Wadud, Peshawar Medical College, Peshawar

Professor,
Department of Physiology,
Peshawar Medical College, Peshawar

Sara Yar Khan, Peshawar Medical College, Peshawar

Assistant Professor,
Department of Biochemistry,
Peshawar Medical College, Peshawar

Momina Haq, Peshawar Medical College, Peshawar

Professor,
Department of Physiology,
Peshawar Medical College, Peshawar

References

Shoukat S, et al. Impact of vitamin D on respiratory function and immune health in patients with chronic obstructive pulmonary disease: a systematic review. Pak J Chest Med. 2022;28(4):522-9

Rafiq R, et al. Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial. Am J Clin Nutr. 2022;116(2):491-9. https://doi.org/10.1093/ajcn/nqac083 PMID: 35471440

Anitua E, Tierno R, Alkhraisat MH. Role of vitamin D supplementation in respiratory infections and COPD exacerbations. Clin Nutr. 2022;41(3):755-77. https://doi.org/10.1016/j.clnu.2022.01.029 PMID: 35101247 DOI: https://doi.org/10.1016/j.clnu.2022.01.029

Williamson A, et al. Vitamin D for management of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2024;9(9):CD013284. https://doi.org/10.1002/14651858.CD013284.pub2 PMID: 39218763 DOI: https://doi.org/10.1002/14651858.CD013284.pub2

Giustina A, et al. Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocr Rev. 2024;45(5):625-54. https://doi.org/10.1210/endrev/bnae009 PMID: 38446731 DOI: https://doi.org/10.1210/endrev/bnae009

Wang Y, et al. Efficacy of vitamin D supplementation on COPD and asthma control: systematic review and meta-analysis. J Glob Health. 2022;12:04100. https://doi.org/10.7189/jogh.12.04100 PMID: 36405572 DOI: https://doi.org/10.7189/jogh.12.04100

Rocha L, Figueiredo B, Martins SE. Importance of vitamin D supplementation in prevention of COPD exacerbations: evidence-based review. Cureus. 2025;17(2):e79787. https://doi.org/10.7759/cureus.79787 DOI: https://doi.org/10.7759/cureus.79787

Jolliffe DA, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2021;9(5):276-92. https://doi.org/10.1016/S2213-8587(21)00051-6 PMID: 33798465 DOI: https://doi.org/10.1016/S2213-8587(21)00051-6

Burkes RM, et al. Associations among 25-hydroxyvitamin D levels, lung function, and exacerbation outcomes in COPD. Chest. 2020;157(4):856-65. https://doi.org/10.1016/j.chest.2019.11.047 PMID: 31830527 DOI: https://doi.org/10.1016/j.chest.2019.11.047

Köktürk N, et al. Vitamin D status in hospitalized patients with chronic obstructive pulmonary disease. Tuberk Toraks. 2020;68(1):25-34. https://doi.org/10.5578/tt.66351 PMID: 32293889 DOI: https://doi.org/10.5578/tt.66351

Kim C, et al. Severe vitamin D deficiency is associated with emphysema progression in male COPD patients. Respir Med. 2020;163:105890. https://doi.org/10.1016/j.rmed.2020.105890 PMID: 32151984 DOI: https://doi.org/10.1016/j.rmed.2020.105890

Mathyssen C, et al. Local expression profiles of vitamin D-related genes in airways of COPD patients. Respir Res. 2020;21(1):137. https://doi.org/10.1186/s12931-020-01405-0 PMID: 32460873 DOI: https://doi.org/10.1186/s12931-020-01405-0

Jorde I, et al. Association of serum vitamin D levels with disease severity and exacerbations in COPD. J Thorac Dis. 2021;13(6):3597-609. https://doi.org/10.21037/jtd-20-3221 PMID: 34221591 DOI: https://doi.org/10.21037/jtd-20-3221

Fu L, et al. Low vitamin D status is associated with inflammation in COPD patients. J Immunol. 2021;206(3):515-23. https://doi.org/10.4049/jimmunol.2000964 PMID: 33355173 DOI: https://doi.org/10.4049/jimmunol.2000964

Lokesh KS, et al. Vitamin D deficiency is associated with chronic obstructive pulmonary disease and exacerbations. Clin Respir J. 2021;15(4):389-99. https://doi.org/10.1111/crj.13310 PMID: 33411973 DOI: https://doi.org/10.1111/crj.13310

Calle Rubio M, et al. Testing for vitamin D in high-risk COPD patients in Spain: VITADEPOC study. J Clin Med. 2022;11(5):1347. https://doi.org/10.3390/jcm11051347 PMID: 35268453 DOI: https://doi.org/10.3390/jcm11051347

Lee CY, et al. Association between vitamin D level and respiratory symptoms in stable COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:579-90. https://doi.org/10.2147/COPD.S326037 PMID: 35399479 DOI: https://doi.org/10.2147/COPD.S326037

Rafiq R, et al. Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: randomized controlled trial. Am J Clin Nutr. 2022;116(2):491-9. https://doi.org/10.1093/ajcn/nqac083 PMID: 35471440 DOI: https://doi.org/10.1093/ajcn/nqac083

Wang L, et al. Correlations of IL-1β and vitamin D with CAT score in acute exacerbation of COPD. Cell Mol Biol (Noisy-le-grand). 2023;69(15):21-5. https://doi.org/10.14715/cmb/2023.69.15.4 PMID: 38100691 DOI: https://doi.org/10.14715/cmb/2023.69.15.4

Kola I, et al. Vitamin D status in COPD patients at Chris Hani Baragwanath Hospital, South Africa. Afr J Thorac Crit Care Med. 2024;30(3):e1041. https://doi.org/10.7196/AJTCCM.2024.v30i3.1041 DOI: https://doi.org/10.7196/AJTCCM.2024.v30i3.1041

Jiang Q, et al. Nonlinear correlation between serum 25-hydroxyvitamin D and all-cause mortality in COPD. Front Nutr. 2024;11:1412606. https://doi.org/10.3389/fnut.2024.1412606 PMID: 38952952 DOI: https://doi.org/10.3389/fnut.2024.1412606

Lakra A, et al. Relationship between vitamin D3 levels and acute exacerbation risk in COPD. Monaldi Arch Chest Dis. 2025;95(1). https://doi.org/10.4081/monaldi.2024.2885 DOI: https://doi.org/10.4081/monaldi.2024.2885

Jiang Y, et al. Correlation between vitamin D, inflammatory markers, and T lymphocytes with COPD severity and exacerbation risk. Clin Ther. 2025;47(1):44-54. https://doi.org/10.1016/j.clinthera.2024.10.003 DOI: https://doi.org/10.1016/j.clinthera.2024.10.003

Zhou L, Han C, Zhou Y. Severe vitamin D deficiency and risk of severe exacerbation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2025;20:171-9. https://doi.org/10.2147/COPD.S489650 DOI: https://doi.org/10.2147/COPD.S489650

Han Z, et al. Nonlinear association between serum vitamin D concentrations and lung function in adults with COPD. Sci Rep. 2025;15(1):7474. https://doi.org/10.1038/s41598-025-90354-z DOI: https://doi.org/10.1038/s41598-025-90354-z

Rus LA, et al. Lower vitamin D during acute exacerbation is associated with severe COPD. Medicina (Kaunas). 2025;61(6):979. https://doi.org/10.3390/medicina61060979 DOI: https://doi.org/10.3390/medicina61060979

Sun M, et al. Role and clinical significance of vitamin D in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2025;20:2023-33. https://doi.org/10.2147/COPD.S520795 DOI: https://doi.org/10.2147/COPD.S520795

Fekete M, et al. Effectiveness of supplementation with vitamins and antioxidants in COPD: a review. Nutrients. 2023;15(12):2741. https://doi.org/10.3390/nu15122741 PMID: 37374152 DOI: https://doi.org/10.3390/nu15122741

Hua Y, et al. Negligible effect of vitamin D supplementation on COPD exacerbation: meta-analysis. Biochem Med (Zagreb). 2023;33(3):030703. https://doi.org/10.11613/BM.2023.030703 PMID: 37521203 DOI: https://doi.org/10.11613/BM.2023.030703

Gold DR, et al. Vitamin D supplementation, COPD and asthma exacerbations, and lung function decline. J Nutr. 2025;155(5):1417-28. https://doi.org/10.1016/j.tjnut.2025.02.003 DOI: https://doi.org/10.1016/j.tjnut.2025.02.003

Valle MS, et al. Anti-inflammatory role of vitamin D in muscle dysfunction in COPD patients: a review. Minerva Med. 2023;114(3):357-71. https://doi.org/10.23736/S0026-4806.22.07879-X PMID: 36366954 DOI: https://doi.org/10.23736/S0026-4806.22.07879-X

Jolliffe DA, et al. Vitamin D supplementation to prevent acute respiratory infections: stratified aggregate data meta-analysis. Lancet Diabetes Endocrinol. 2025;13(4):307–20. https://doi.org/10.1016/S2213-8587(24)00348-6 DOI: https://doi.org/10.1016/S2213-8587(24)00348-6

Shah VP, et al. Systematic review supporting Endocrine Society clinical practice guidelines on vitamin D. J Clin Endocrinol Metab. 2024;109(8):1961-74. https://doi.org/10.1210/clinem/dgae312 PMID: 38709122 DOI: https://doi.org/10.1210/clinem/dgae312

Simon P, et al. Nutritional support of chronic obstructive pulmonary disease. Nutrients. 2025;17(7):1149. https://doi.org/10.3390/nu17071149 DOI: https://doi.org/10.3390/nu17071149

Onur T, et al. Evaluation of micronutrients in stable COPD patients. Asia Pac J Clin Nutr. 2025;34(5):724-9. https://doi.org/10.6133/apjcn.202510_34(5).0002

Downloads

Published

2026-06-30

How to Cite

Sikandar Ali Khan, Hina Hakim, Farzana Salman, Shamaila Wadud, Sara Yar Khan, & Momina Haq. (2026). Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review. Journal of Gandhara Medical and Dental Science, 13(3), 132–142. https://doi.org/10.37762/jgmds.13-3.890